Thank you for posting. You bring up valid concerns...and yes, I think all the companies in the space are taking advantage of the down market to add the write offs now, because investors will blame the market conditions and sweep it under the rug. The company gets to move forward less that dead weight and expecting to look better in the quarters to come. I need to go back and look to see what the total is for the top US operators. We have to be around $1B in goodwill/impairment, and that is without Curaleaf, who will probably report about half of that amount on their own. I am glad you shed light on the preferred stock, and dividends. It is on my radar but I (personally) tend to give it a pass because I see how the company is operating, where it is going, and believe it will work itself out in the end (which is probably an investor flaw). As for saturation, I dont ignore it...and, quite frankly I like the lack of license controls. Obviously it is challenging to any business operating under the conditions...but it is also trial by fire. The strong will survive and consumers benefit from the competition...both in quality and price. I like how the operators arent all controlled by big money...and there isnt any 'social equity' license flip. Just sick of these alleged top-operators using their access to capital to get regulators to implement license limits, lock down the licenses, squashing home grow and forcing their moldy garbage down consumers throats for a premium. That's my investment strategy in in a nutshell...and the reason I will continue buying SHWZ (but not reaching...waiting). I prefer a company that is proving their worth while operating in the foxhole as opposed to one making a name for themselves by continuously seeking asylum.
